Cancer, Lung
39
5
7
15
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
2.6%
1 terminated out of 39 trials
93.8%
+7.2% vs benchmark
8%
3 trials in Phase 3/4
27%
4 of 15 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 15 completed trials
Clinical Trials (39)
Feasibility Study of Personalized Ultra-fractionated Stereotactic Ablative Radiotherapy (PULSAR) for Cancers of the Central Lung
Follow-up of Pulmonary Radiotoxicity for Bronchopulmonary Cancer.
Evaluation of the Medical Service by Socio-aesthetics in Oncology
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
Precision Lung Cancer Survivorship Care Intervention
Exploration of Circulating microRNAs as Biomarkers of Chemo-induced Peripheral Neuropathy: a Study in Cancer Patients
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Clinical Validation of an MCED Test in Symptomatic Populations (K-ACCELERATE)
Genomic Testing and Resulting Medical Decisions
Early Detection of Five Common Cancers Using the ctDNA Analysing Test
Quantitative Lung Cancer Screening
Influence of a Home-based Nutrition and Exercise Program on Quality of Life of Palliative Cancer Outpatients
Quest to Analyze One Thousand Humans Meditating
A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors
Analysis of Lung Cancer Tissue With Spatial Frequency Domain Imaging
Exercise Effect on Chemotherapy-Induced Neuropathic Pain
Effect of NUTRICAN to Improve Nutritional Status in Cancer Patients
Radiogenomics in Aerodigestive Tract Cancers
Exploratory Drug Interaction Study Between SMIs and DOACs
Nivolumab and Ipilimumab +/- UV1 Vaccination as Second Line Treatment in Patients With Malignant Mesothelioma